Active Pharmaceutical Ingredients
Orlistat IR Pellets are designed for immediate oral delivery of Orlistat, a gastrointestinal lipase inhibitor used in the management of obesity by reducing dietary fat absorption. Using advanced pelletization technology, these pellets ensure rapid disintegration and API release in the gastrointestinal tract without the need for enteric protection. Their multiparticulate nature enhances dosing flexibility and reduces variability in absorption, making them suitable for modern oral formulations such as capsules and sachets.
| Component | Function |
|---|---|
| Orlistat | Active Pharmaceutical Ingredient (API) |
| Microcrystalline Cellulose (MCC) | Inert core |
| Povidone K30 (PVP K30) | Binder |
| Sodium Starch Glycolate | Superdisintegrant |
| Sodium Lauryl Sulfate (SLS) | Surfactant |
| Talc | Anti-adherent |
| Colloidal Silicon Dioxide | Glidant |
| Purified Water / IPA | Solvent system (evaporated during processing) |
Salius Pharma offers Orlistat IR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India. Our pellets are engineered using optimized extrusion-spheronization and layering techniques to ensure uniform pellet size, superior flow, and rapid drug release. We offer tailored strengths and particle size distribution to meet specific formulation needs. With extensive experience in global export and regulatory support, our pellets are ideal for inclusion in weight-loss products across regulated and semi-regulated markets.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Orlistat IR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Yes, our pellets are manufactured in WHO-GMP and USFDA-approved facilities and meet pharmacopeial standards (BP/EP/ USP), ensuring smooth registration and acceptance in different markets.
We offer customized bulk packaging with moisture-protective liners. Products are shipped via validated cold chain or ambient logistics based on regulatory and climatic requirements.
Absolutely. We offer customizable strengths (typically 10–30%) and particle size ranges suitable for direct encapsulation or sachet formulation, depending on client formulation needs.
We supply a complete regulatory dossier including COA, MSDS, Method of Analysis, Stability Data, and product-specific CTD modules upon request for dossier submissions.